Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Myeloproliferative Neoplasms.

× No keyword cloud information.

93 in total

Review 1. Novel and combination therapies for polycythemia vera and essential thrombocythemia: the dawn of a new era.

Authors: Jan Philipp Bewersdorf; Amer M Zeidan
Journal: Expert Rev Hematol Date: 2020-11-01 Impact factor: 2.929

Review 2. Management of Myelofibrosis-Related Cytopenias.

Authors: Prithviraj Bose; Srdan Verstovsek
Journal: Curr Hematol Malig Rep Date: 2018-06 Impact factor: 3.952

3. Neo-antigen specific memory T-cell responses in healthy individuals.

Authors: Morten Orebo Holmström; Hans Carl Hasselbalch; Mads Hald Andersen
Journal: Oncoimmunology Date: 2019-04-19 Impact factor: 8.110

Review 4. New Concepts of Treatment for Patients with Myelofibrosis.

Authors: Prithviraj Bose; Mansour Alfayez; Srdan Verstovsek
Journal: Curr Treat Options Oncol Date: 2019-01-24

Review 5. SOHO State-of-the-Art Update and Next Questions: MPN.

Authors: Prithviraj Bose; Jason Gotlib; Claire N Harrison; Srdan Verstovsek
Journal: Clin Lymphoma Myeloma Leuk Date: 2018-01

6. Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms.

Authors: Simona Stivala; Tamara Codilupi; Sime Brkic; Anne Baerenwaldt; Nilabh Ghosh; Hui Hao-Shen; Stephan Dirnhofer; Matthias S Dettmer; Cedric Simillion; Beat A Kaufmann; Sophia Chiu; Matthew Keller; Maria Kleppe; Morgane Hilpert; Andreas S Buser; Jakob R Passweg; Thomas Radimerski; Radek C Skoda; Ross L Levine; Sara C Meyer
Journal: J Clin Invest Date: 2019-03-04 Impact factor: 14.808

Review 7. Polycythemia Vera.

Authors: Jerry L Spivak
Journal: Curr Treat Options Oncol Date: 2018-03-07

Review 8. Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms.

Authors: Tariq I Mughal; Jason Gotlib; Ruben Mesa; Steffen Koschmieder; H Jean Khoury; Jorge E Cortes; Tiziano Barbui; Rüdiger Hehlmann; Michael Mauro; Susanne Saussele; Jerald P Radich; Richard A Van Etten; Giuseppe Saglio; Srdnan Verstovek; Robert Peter Gale; Omar Abdel-Wahab
Journal: Leuk Res Date: 2018-02-14 Impact factor: 3.156

9. Time for revival of the red blood cell count and red cell mass in the differential diagnosis between essential thrombocythemia and polycythemia vera?

Authors: Hans Carl Hasselbalch
Journal: Haematologica Date: 2019-11 Impact factor: 9.941

10. Clinical outcomes of interferon therapy for polycythemia vera and essential thrombocythemia: a systematic review and meta-analysis.

Authors: Wenjing Gu; Renchi Yang; Zhijian Xiao; Lei Zhang
Journal: Int J Hematol Date: 2021-06-06 Impact factor: 2.490